Tumor testing aims to match patients with targeted cancer drugs
NCT ID NCT01505400
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 15 times
Summary
This study collects previously stored tumor samples from over 3,000 people with advanced cancers like breast, lung, and colorectal cancer. Researchers test the samples for specific biomarkers—molecular clues that can help doctors choose which targeted therapy or clinical trial might work best for each patient. The goal is to learn how often this information is used and whether it helps patients get into the right trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.